Dr Rajesh Madhu MRCPCH, MSc
Dr Rajesh Madhu is a Consultant in the Neurosciences Department and the Clinical Lead for the Neuromuscular Services at Alder Hey hospital. He completed his Masters degree in Genomic Medicine from the University of Manchester and lead the Genomic Medicine service for Neuromuscular Disorders. They provide advanced diagnostic investigations for children with suspected Neuromuscular Disorders including whole genome sequencing. They offer multidisciplinary care to children and deliver advanced disease modifying genetic treatments, including gene therapy, for children with neuromuscular disorders.
He ran the specialist clinics for the following conditions
- Spinal Muscular Atrophy (SMA) – children with this condition get comprehensive evaluation and treatment with Zolgensma gene therapy as well as Nusinersen and Risdiplam genetic treatments
- Duchenne Muscular Dystrophy
- Myotonic Dystophy
- Limb girdle Muscular dystrophy
- Congenital myasthenia syndromes
- Friedrich’s Ataxia
- Congenital Myopathies
- Joint neuropathy
- Arthrogryposis
He also lead the neuromuscular research at Alder Hey. JHe is the Principal investigator/ co- PI for various clinical trials in neuromuscular disorders, including the exon skipping trials, and gene therapy trial in DMD.He is also the Principal investigator for the SOLVE-RD genomic sequencing study.